HPV Vaccine Often Not Received at Recommended Age
(HealthDay News) — Only about half of American girls begin receiving the human papillomavirus (HPV) vaccine at the recommended age, according to a study published in the January 29 issue of Vaccine.
Girls should begin getting the three-dose HPV vaccine when they are 11 or 12. The vaccine is most effective before girls become sexually active, according to the U.S. Centers for Disease Control and Prevention. The CDC also recommends the vaccine for boys beginning at ages 11 or 12. However, the current study only looked at girls.
"Rates of HPV infection increase significantly every year for young people between 14 and 24, so vaccination at a young age is very important," team leader Mahbubur Rahman, MBBS, PhD, MPH, of the University of Texas Medical Branch at Galveston, said in a university news release. He is an associate professor in the obstetrics and gynecology department at the university.
The researchers found that the number of girls in the United States who started the vaccine series at the recommended age was 14% in 2008. By 2012, that number was 56%. The trends did not differ by race or ethnicity. The findings showed that nearly half of adolescent girls receive the vaccine after age 12 – and researchers said it's not certain how effective the vaccine is after this age. "It's important that parents and health care providers are aware of the importance of early HPV vaccination to ensure that girls receive this vaccination at the CDC's recommended age," Rahman added.